News & Events for Human Drugs

Recent New and Generic Drug Approvals

7-day and 14-day reports from Drugs@FDA

New Drugs at FDA

CDER’s New Molecular Entities and New Therapeutic Biological Products

Meetings, Conferences, & Workshops

Sponsored or co-sponsored by Center for Drug Evaluation and Research

Advisory Committee Calendar

Notices of advisory committee meetings

CDERLearn Training and Education

Learning opportunities for healthcare professionals, industry, consumers, and academia

Tools To Keep You Informed

Mobile apps, podcasts, webinars, videos, and more

Notable Approvals | Drugs

News about human drug-related approvals

From Our Perspective

Insider’s look at changes, initiatives and advances in drug development, review and approval

White text that reads "Regulatory Science Impact Story" on blue background

Impact Stories

Stories illustrating how regulatory science impacts the lives and health of people

CDER Conversations

Discussions with key CDER leadership about important regulatory and policy issues

Drug Information Soundcast in Clinical Oncology (D.I.S.C.O.)

New product approvals, emerging safety info for cancer treatments, and other topics in cancer drug development

Spotlight on CDER Science

CDER Scientists describe scientific advancements aimed at improving drug development

Director's Corner Podcasts

Listen to an audio series featuring former CDER Director Dr. Janet Woodcock

Paragraph Header

Contact FDA

Contact Point

Office of Communications
10001 New Hampshire Ave
Hillandale Building, 4th Fl
Silver Spring, MD 20993

druginfo@fda.hhs.gov

Toll Free

(855) 543-3784

(301) 796-3400

Hours Available

CDER Division of Drug Information

For Updates on Twitter follow

Contact Point Twitter

@FDA_Drug_Info

Your source for the latest drug information.
Know the moment it happens.

U.S. Food and Drug Administration